Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | MMP9 | P14780 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | MMP8 | P22894 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
| ▸ | CDK2 | P24941 | 1/20 | 0.33 |
| ▸ | MMP12 | P39900 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28515636 | 1.00 | ADAMTS4 (0.33) | ADAMTS4ALDH1A1EGFRCA1CA2 | |
| SCHEMBL5154627 | 0.85 | NPC1 (0.32) | ALDH1A1EGFRCA2LMNAFYN | |
| SCHEMBL30727395 | 0.85 | NPC1 (0.32) | ALDH1A1EGFRCA2LMNAFYN | |
| SCHEMBL1068646 | 0.73 | KDM4E (0.35) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| SCHEMBL30658588 | 0.73 | KDM4E (0.35) | ALDH1A1HPGDALOX15RECQLHSD17B10 | |
| SCHEMBL3115931 | 0.71 | CYP2C19 (0.35) | ALOX15 | |
| SCHEMBL28684184 | 0.71 | — | — | |
| SCHEMBL2679220 | 0.70 | EDNRB (0.32) | — | |
| SCHEMBL28574006 | 0.70 | MEN1 (0.32) | CA1CA2ALOX15 | |
| SCHEMBL3698500 | 0.68 | CA1 (0.39) | ALDH1A1CA1CA2LMNAMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112168731-A | Composition for improving skin elasticity or skin wrinkles containing heptahydroxyflavan as an active ingredient | 株式会社爱茉莉太平洋 | 2021-01-05 | — | — | CN | claimed |
| US-11554091-B2 | Composition for enhancing skin elasticity or improving skin wrinkles comprising heptahydroxyflavan as an effective ingredient | AMOREPACIFIC CORPORATION (KR) | 2023-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11554091-B2 | Composition for enhancing skin elasticity or improving skin wrinkles comprising heptahydroxyflavan as an effective ingredient | MMP13, MMP3, MMP1 | ADAMTS4 67/4885ALDH1A1 1616/4885EGFR 1838/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.